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Abstract
Monitoring patent ductus arteriosus (PDA) in premature infants is currently performed intermittently using echocardiography 
which requires considerable expertise. The aim of this pilot study was to investigate whether PDA status could be assessed 
from standard neonatal intensive care monitoring. Electrocardiography (ECG) and blood pressure (BP) waveforms were 
acquired from extremely preterm infants using standard neonatal monitors. We developed software using MATLAB to analyse 
ECG and BP waveforms and their interrelationships in terms of pulse transit time (PTT) and pulse wave velocity (PWV). 
The times from peak systolic BP to diastolic trough (BPFt) and from the diastolic trough to peak systolic BP (BPRt) were 
also calculated. PTT, BPFt and BPRt were normalised for heart rate (HR) termed NPTT, NBPFt and NBPRt, respectively. 
ECG, invasive aortic BP monitoring and echocardiography were performed in 14 preterm infants < 29 weeks’ gestation in 
the first 3 days after birth. The median (range) birth weight of the infants was 0.90 (0.48–1.31) kg, gestation 26.6 (24.0–28.7) 
weeks, PDA diameter 1.6 (0.8–3.6) mm and mean BP 32 (16–40) mmHg. We found a significant positive correlation between 
PDA diameter and NPTT (r = 0.69, P = 0.007) as well as NBPFt (r = 0.65, P = 0.012) and NBPRt (r = 0.71, P = 0.005). No 
relationship was found between PDA diameter and pulse pressure.
Conclusions: Interrelationships between ECG and BP traces as well as BP waveform time analysis are straightforward 
to measure and associated with PDA diameter. The results of this pilot study suggest that this approach may help provide 
biomarkers for continuous monitoring PDA diameter and function.
What is Known:
• Patent ductus arteriosus (PDA) in premature infants is associated with increased risk of developing chronic lung disease, necrotising entero-
colitis and cerebral injury.
• Currently PDA is assessed intermittently using echocardiography which requires considerable expertise and sometimes is not well tolerated 
by critically ill preterm infants.
What is New:
• Blood pressure (BP) and ECG waveform interrelation and BP trace time analysis, taking account of heart rate, relate to PDA diameter.
• ECG and BP waveform phase difference as well as BP waveform time analysis may be useful in the continuous assessment of PDA function.
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Abbreviations
BPFt  BP fall time (peak systole to end diastole of 
BP waveform)
BPRt  BP rise time (end diastole to peak systole of 
next beat in BP waveform)
BP  Blood pressure
BW  Birth weight
ECG  Electrocardiogram
EPIs  Extremely preterm infants
HR  Heart rate
IVRT  Isovolumic relaxation time
MIVCT  Isovolumic contraction time
NBPFt  BP fall time (peak systole to end diastole of 
BP waveform) normalised for heart rate
NBPRt  BP rise time (end diastole to peak systole of 
next beat in BP waveform) normalised for 
heart rate
NMIVCT  Isovolumic contraction time normalised for 
heart rate
NPTT  Pulse transit time normalised for heart rate
PDA  Patent ductus arteriosus
PTT  Pulse transit time
PWV  Pulse wave velocity
Introduction
Patent ductus arteriosus (PDA) has significant effects on 
cardiac and aortic haemodynamics as blood flow through 
the PDA reduces flow to the systemic circulation and 
overperfuses the lungs. PDA is associated with many 
neonatal comorbidities [1, 2]. Effective treatments for PDA 
are available [3]; however, there is no consensus for the 
definition of the haemodynamically significant PDA, and 
the decision for treatment is based on a combination of 
echocardiographic and clinical criteria. Echocardiography, 
the gold standard for PDA assessment, is assessed 
intermittently, requires considerable expertise and is 
sometimes not well tolerated by extremely preterm infants 
(EPIs) [4].
Pulse transit time (PTT) is of value in monitoring blood 
pressure (BP) changes in adults [5]. Different methods are 
used to measure PTT, but typically the time difference 
between ECG and pulse oximetry plethysmogram traces are 
determined with an oximeter probe placed on limbs [6]; the 
difference in time between the ECG R wave and the mid-
way of the following corresponding plethysmographic trace 
upswing is measured [7]. Pulse wave velocity (PWV) can be 
calculated from the physical length between the heart and 
the oximeter probe divided by PTT. Aortic PWV is a marker 
for cardiovascular events in adults [8] as well as having use 
in monitoring BP [9].
In most UK neonatal intensive care units, EPIs may have 
an umbilical artery catheter (UAC) for BP monitoring in the 
days after birth, the tip of which lies in the descending aorta 
close to the ductus arteriosus insertion. However, there has 
been little reported use of PWV or PTT in preterm infants 
probably in part due to the high heart rate (HR) and small 
physical lengths making the measurement precision have 
greater influence. As high-resolution digital recording of 
ECG and BP is now available, PWV and PTT in neonates 
can be more easily determined. This study aimed to investi-
gate whether there are changes in PTT, PWV and BP wave 
characteristics in EPIs associated with PDA diameter.
Methods
This was a nested cohort study within a prospective observa-
tional study investigating whether there is a relation between 
PDA and brain haemodynamics (North West Lancaster eth-
ics committee, REC reference: 14/NW/1274). All neonates 
admitted to Liverpool Women’s Hospital between  24+0- and 
 28+6–week gestation and postnatal age ≤ 72 h were recruited 
during the period between August 2015 and December 
2016 with parental consent given either pre- or postnatally. 
Only babies with recorded BP waveform from a UAC were 
entered into the current study.
The exclusion criteria were non-viability, chromosomal 
anomalies or other malformations likely to affect cardiovas-
cular adaptation and intraventricular haemorrhage grades 
3–4 in the cranial ultrasonography after birth.
Clinical physiological monitoring
ECG and BP were monitored for clinical reasons in accord-
ance with standard neonatal intensive care using Philips 
IntelliVue MX800 patient monitors (Philips Healthcare, 
UK). The data were recorded from the monitors by inter-
facing with a laptop via Bluetooth using IxTrend software 
(ixellence GmbH, Wildau, Germany) and shortly before 
echocardiography on that day.
Invasive BP monitoring
Invasive BP data were only captured when BP monitoring was 
clinically indicated. A 3.5F UAC (Vygon, Swindon, UK) was 
positioned between the sixth and tenth thoracic vertebra and 
connected to an electronic pressure transducer via a 38-cm-long 
rigid plastic extension catheter tubing. The distance from the BP 
transducer was thus made up of 37 cm (UAC length) + 38 cm 
(extension length) giving a total of 75 cm distance. The ECG 
and BP waveforms on the monitor screen were visually assessed 
to ensure good quality signal with no apparent movement 
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artefact. Indicators of poor BP signal quality were an abnormal 
shape waveform (indicating damping with air in the circuit) or 
a low pulse pressure (indicating partially blocked UAC); the BP 
transducer was positioned at the level of the heart. A low pass 
filter cut-off frequency at 12 Hz was applied by the monitor to 
the BP waveform and the output exported with 125 Hz sampling 
frequency.
Electrocardiogram (ECG)
Standard neonatal ECG for clinical monitoring was applied 
and lead I selected. ECG and BP monitoring data were 
downloaded from monitors and stored as spreadsheet files 
using the IxTrend software. The ECG waveform data were 
acquired with 500 Hz sampling rate (filter range 0. to 55 Hz).
Assessment of ECG and BP interrelation and BP 
waveform measurements
Using MATLAB (The MathWorks Inc., USA), we devel-
oped software to read, display and analyse the ECG and BP 
spreadsheet files collected using IxTrend. PTT was defined 
in our study as the difference in time between the ECG 
R wave and the following systolic BP peak (Fig. 1). The 
systolic BP peak was used to enable precise identification 
of a consistent point in the cardiac cycle; this is important 
because of the high HR in preterm neonates. 
For PWV the distance along the blood vessels from the 
aortic valve to the UAC tip was estimated. As the catheter 
tube connecting to the pressure transducer is rigid, it was 
assumed this would have negligible effect on PWV calcula-
tion; the catheter position was confirmed by X-ray imaging. 
The aortic valve is radio translucent with no clear landmark 
to identify it; from adult data, the relation of the aortic valve 
to vertebral level varies around the middle third of the sev-
enth thoracic vertebra [10]. There are no corresponding data 
for preterm infants, and hence, we reviewed CT scans from 
the term infants with cardiac conditions and found that the 
relation of the aortic valve to the vertebral level varied but 
mostly was around the 6th thoracic vertebra. The distance 
of the catheter tip from the assumed position of the aortic 
valve could thus be traced using PACS software (Phillips, 
London, UK).
As PTT and PWV are affected by HR, PTT was expressed 
as a fraction of the RR interval to normalise for HR. Thus, 
NPTT is the difference in time between the ECG R wave 
and the following systolic BP peak expressed as the propor-
tion of one cardiac cycle, R–R interval length (L) (Fig. 1A); 
NPTT is thus the ratio PTT/L.
The median HR, PTT and NPTT over 10 s were com-
puted by our custom software in two sections with little or 
no artefact. The sections were 10 min apart unless there 
was artefact in which case the second section was as close 
to 10 min later as possible. The software also calculated the 
minimum and maximum BP for each cardiac cycle as well 
as the pulse pressure and mean BP calculated based on the 
systolic and diastolic values (diastolic + 1/3 pulse pressure) 
[11]. The software also calculated the time from peak sys-
tolic BP to the trough in diastole termed BP fall time (BPFt) 
and the time from the BP trough in diastole to the following 
peak systolic BP, termed BP rise time (BPRt). As the meas-
urements could potentially be affected by HR, the data were 
also normalised with respect to HR, i.e. the proportion of 
one cardiac cycle, giving three new measurements termed 
NPTT, NBPFt and NBPRt, respectively. To assess which 
component of cardiac cycle is mainly affected by PDA, a 
surrogate of isovolumic contraction time was calculated by 
deducting BPRt from PTT termed MIVCT and expressed as 
a ratio normalised to HR (NMIVCT).
Echocardiography and cerebral Doppler blood flow 
velocity
Echocardiography and cerebral ultrasonography were per-
formed daily in the first 3 days after birth using a Vivid-E9 
machine with a 12 MHz phased array probe (GE Medical, 
Milwaukee, USA). PDA diameter was measured from the 
high parasternal view at the narrowest point [12]. Multiple 
echocardiographic parameters were measured as previously 
described [13]. Cerebral Pourcelot resistance index (PI) 
from Doppler ultrasound measurements was computed as it 
is based on the blood flow velocity waveform [14]. Images 
and videos were acquired and analysed offline by a single 
observer (CK).
Statistics
Statistical analysis was performed using Minitab v19 
(Minitab LLC., USA). Data were tested for consistency 
with a normal distribution using the Ryan-Joiner test and 
parametric or non-parametric statistics used as necessary. 
Median and range were used to describe summary demo-
graphics. Bland and Altman plots [15] were used to assess 
the repeatability of the data separated by 10 min. Pearson’s 
correlation coefficient was used to assess the relationship 
between the aortic biomarkers with demographic and cardio-
vascular parameters. In view of multiple comparisons, the 
Benjamini and Hochberg procedure [16] was applied with 
10% false discovery rate.
Results
Fourteen infants were studied in the first 3 days after birth, 
and a single measurement was analysed for each infant. The 
demographic details of our population and a summary of 
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measurements are shown in Table 1. In summary the median 
(range) birth weight (BW) was 0.90 (0.48–1.31) kg, gestation 
26.6 (24.0–28.7) weeks, PDA diameter 1.6 (0.8–3.6) mm, HR 
147 (111–191)/min and mean BP at the measurement time was 
32 (16–40) mmHg. Four neonates received inotropes (dopa-
mine and/or dobutamine); of these one subsequently had a 
severe intraventricular haemorrhage and three later died. In one 
recording, the infant was clearly hypotensive with systolic BP 
25 mmHg and diastolic 11 mmHg, mean 16 mmHg. There was 
a significant relationship between PTT and gestation (r = 0.55, 
95% CI (0.03, 0.84), P = 0.040), but not with BW (r = 0.39, 
95% CI (−0.17, 0.76), P = 0.165). Furthermore, there was a 
significant relationship between NPTT and BW (r = 0.57, 95% 
CI (0.05, 0.84), P = 0.035), but not gestation (r = 0.40, 95% CI 
(−0.16, 0.77), P = 0.154).
Visual analysis of BP waveform morphology indicated 
changes associated with PDA diameter; infants with large 
PDA diameter had the dicrotic notch towards the end of 
the dicrotic limb and had a smoother dicrotic limb without 
superimposed pressure perturbations (Fig. 1B).
A summary of the BP waveform characteristics and echo-
cardiographic parameters compared with PDA diameter is 
shown in Table 2 part A. When comparing with PDA diam-
eter, there was no apparent relationship either with PTT or 
the non-normalised BP waveform measurements (Table 2 
part A and Fig. 2A). However, there were statistical sig-
nificant relationships between the normalised BP waveform 
measurements as well as NPTT when compared with PDA 
diameter (Table 2 part A and Fig. 2B). There were statisti-
cally significant positive correlations between NPTT and 
Fig. 1  A Cardiac cycle length 
(L) is readily measured from 
the ECG as well as the time 
difference PTT (A) between the 
ECG R wave (red triangle) and 
the following BP systolic peak 
(blue square). The ratio PTT:L 
gives a dimensionless index 
NPTT that is normalised to HR. 
The difference in time between 
peak systole and end diastole 
(BPFt) is shown as B. The 
difference in time between end 
diastole and the following peak 
in systole (BPRt) is shown as 
C. The surrogate for isovolumic 
contraction time (MIVCT) was 
calculated as PTT (A)–BP rise 
time (C) in a single cardiac 
cycle. B Two examples of ECG 
(lower) and BP (upper) wave-
forms of two seconds duration 
with different PDA diameters. 
Infants with larger PDA had the 
dicrotic notch displayed towards 
the end of the dicrotic limb 
which can be attributed to the 
lower overall arterial resistance 
due to higher run off from the 
large PDA
European Journal of Pediatrics 
1 3
PDA diameter (r = 0.69, P = 0.007) as well as BP max to min 
(NBPFt) (r = 0.65, P = 0.012) and BP min to max (NBPRt) 
(r = 0.71, P = 0.005) with PDA diameter; inotropic support 
did not have any apparent effect in the aforementioned bio-
markers. HR was found to have a significant relationship 
when comparing with PTT, PWV, left ventricular end dias-
tolic diameter/aortic valve diameter ratio (LVEDD:Ao) and 
E/A wave ratio, but not with PDA diameter (Table 2 and 
Fig. 3). There was no significant correlation between the 
distance of the UAC tip from the aortic valve and NPTT 
(r =  −0.04, 95% CI (−0.56, 0.50), P = 0.880).
Repeatability
 Intra-subject NPTT and BP time difference measurements 
repeatability was good with coefficient of variation 2.4%, 
mean difference 0.00 and standard deviation 0.02 for NPTT 
(Supplement Fig. a) with similar repeatability for BP wave-
form measurements (Supplement Fig. b and c).
Discussion
PDA diameter is generally considered the most useful 
parameter for determining PDA haemodynamic signifi-
cance [17]. Our study used novel straightforward techniques 
to measure BP waveform characteristics and interaction 
between ECG and BP traces in EPIs s and relates them with 
PDA diameter. Associations were clearest when normalis-
ing the characteristics for HR which may be due to the wide 
range of HR seen (110–191/min). Our approach was found 
to have good repeatability and potentially allows continuous 
trend monitoring of the PDA diameter.
Table 1  Summary of demographic data and range of measurements. 
PTT pulse transit time, PWV pulse wave velocity, PDA patent ductus 
arteriosus, BP blood pressure, UAC umbilical artery catheter
Patients n = 14 Median Range (min to max)
Birth weight (kg) 0.9 0.48–1.31
Gestation (weeks) 26.6 24.0–28.7
PTT (s) 0.2 0.14–0.26
PWV (m/s) 2.08 1.30–3.38
Normalised PTT (NPTT) 0.487 0.444–0.586
PDA (mm) 1.6 0.8–3.6
UAC distance from assumed AoV 
(cm)
43 26–53
Heart rate (beats/min) 147 110–191
Mean BP (mmHg) 32 16–40
Cerebral Pourcelot resistance index 
(PI)
0.72 0.58–1.00
Table 2  A Comparison of BP waveform analysis and echocardio-
graphic measurements with PDA diameter showing Pearson’s correla-
tion coefficient confidence interval and P-value (cf: compared with). 
B. Comparison of BP waveform analysis and echocardiographic 
measurements with heart rate showing Pearson’s correlation coeffi-
cient confidence interval and P-value (cf: compared with)
Data in bold shows significant relations taking account of multiple 
comparisons using the Benjamini–Hochberg procedure with a false 
discovery rate of 10%. PTT pulse transit time, NPTT HR normalised 
PTT, BP max to min time (BPFt) and normalised (NBPFt), BP min 
to max time (BPRt) and normalised (NBPRt), isovolumic contraction 
time (MIVCT) and normalised (NMICVT), PWV pulse wave velocity, 
PDA patent ductus arteriosus, LVEDD:Ao left ventricular end dias-
tolic diameter/aortic valve diameter ratio, IVRT isovolumetric relaxa-
tion time, PI Pourcelot resistance index, BP blood pressure
N Correlation 
coeff ρ
95% CI for ρ P-value
A) Variable cf PDA diameter
PTT 14 0.28 (−0.294, 0.706) 0.333
NPTT 14 0.688 (0.247, 0.893) 0.007
BPFt 14  −0.218 (−0.671, 0.354) 0.455
NBPFt 14  −0.647 (−0.877, −0.178) 0.012
BPRt 14 0.337 (−0.235, 0.736) 0.238
NBPRt 14 0.705 (0.279, 0.899) 0.005
MIVCT 14 0.253 (−0.320, 0.691) 0.382
NMIVCT 14 0.457 (−0.097, 0.795) 0.1
PWV 14  −0.301 (−0.717, 0.273) 0.296
Pulse pressure 14 0.101 (−0.454, 0.600) 0.731
Mean BP 14  −0.09 (−0.593, 0.462) 0.758
Cerebral PI 11 0.512 (−0.127, 0.851) 0.107
LVEDD:Ao 12 0.474 (−0.138, 0.824) 0.12
E/A 13 0.494 (−0.078, 0.822) 0.086
IVRT 13  −0.264 (−0.711, 0.336) 0.384
Tip distance 14  −0.185 (−0.652, 0.383) 0.527
Heart rate 14 0.098 (−0.456, 0.598) 0.738
B) Variable cf heart rate
PTT 14  −0.841 (−0.949, −0.562)  < 0.001
NPTT 14 0.177 (−0.390, 0.647) 0.544
BPFt 14  −0.94 (−0.981, −0.817)  < 0.001
NBPFt 14 0.109 (−0.448, 0.604) 0.711
BPRt 14  −0.793 (−0.932, −0.453) 0.001
NBPRt 14 0.023 (−0.514, 0.547) 0.937
MIVCT 14  −0.749 (−0.916, −0.363) 0.002
NMIVCT 14 0.487 (−0.059, 0.809) 0.078
PWV 14 0.701 (0.271, 0.898) 0.005
Pulse pressure 14  −0.382 (−0.759, 0.187) 0.178
Mean BP 14  −0.341 (−0.738, 0.231) 0.232
Cerebral PI 11 0.047 (−0.569, 0.629) 0.892
LVEDD:Ao 12  −0.713 (−0.913, −0.236) 0.009
E/A wave ratio 13  −0.816 (−0.943, −0.480) 0.001
IVRT 13  −0.062 (−0.593, 0.506) 0.839
Tip distance 14 0.355 (−0.216, 0.745) 0.212
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We found that increased PDA diameter was associated 
with longer NBPRt and NPTT and shorter NBPFt. There 
was no significant association between PDA diameter and 
IVRT as well as MIVCT which suggests that the isovolumic 
time intervals are not significantly affected by PDA. The 
presence of a large PDA makes the heart spend a proportion-
ally longer time in ejection during the cardiac cycle. This 
is consistent with a previous study and can be explained as 
PDA increases preload due to increased pulmonary flow and 
decreases afterload, as it connects the systemic circulation 
to the low resistance pulmonary circulation [18]. Hence, as 
the left ventricular volume is increased it takes longer for 
this to be ejected out of the LV. Moreover, it is known that 
increased afterload shortens ejection time [19].
Overall the end diastolic time to peak systolic as a propor-
tion of the R-R interval was about 1/3 with longer values being 
more likely to be associated with larger PDA diameter. In terms 
of a simple model, a PDA can be considered as a parallel pipe 
scenario where the ductus and descending aorta are the pipes; 
the scenario is complicated as the PDA provides a lower resist-
ance channel. Nevertheless considering the simple parallel pipe 
model, the proportion of the cardiac cycle from peak systole to 
end diastole would be expected to be reduced with more flow 
through the PDA as there is an effective ‘steal’ of blood. Alter-
native modelling approaches have been suggested using the 
Moens–Korteweg equation; however, it is based on an acoustic 
approach, and BP is not incorporated [20].
The present study emphasises the importance of report-
ing HR and developing methods for correcting for HR when 
echocardiographic [21] and pulse wave characteristics [22] 
are used to study changes related to PDA in preterm infants. 
PTT was found to be longer after PDA treatment in a study 
of ex-preterm infants when looking at group differences 
[23]; however, the PDA treatment occurred at postnatal age 
ranging from 10 to 79 days. Moreover, the recordings in our 
study were from the descending aorta which is central and 
elastic with lower arterial stiffness compared to peripheral 
(muscular) arteries. A previous study has demonstrated by 
using pre- and post-ductal sites’ pulse wave plethysmog-
raphy that PDA is related to small changes in pulse phase 
difference between oximetry probes on the left foot and right 
hand [24]. Compared to this study, our methodology did not 
Fig. 2  shows the effect of normalising data for HR. Figure 2 A shows non-normalised PTT and BPFt plotted against PDA diameter. Figure 2 B 
shows the relationship of HR normalised data (NPTT and NBPFt) plotted against PDA diameter
European Journal of Pediatrics 
1 3
require extra probes on the baby nor depend on oximeter 
plethysmogram processing.
The values for PWV we observed are consistent with 
a study in children albeit being slightly lower [25]. PDA 
did not affect the pulse pressure in our study which is 
consistent with recent reports [26]. Moreover, it is known 
that the arterial capacitance and not the resistance mainly 
determines the pulse pressure [27]. The dicrotic limb of 
the waveform in our population is smoother and does not 
have the classic appearance of the adult waveform with the 
prominent dicrotic notch and the bumpy systolic decline 
and diastolic runoff phase produced by the higher resist-
ance vasculature and the resultant reflective waves. How-
ever, BP wave appearance may be related to the BP filter 
settings on the monitor.
Limitations
Natural variations of cardiac anatomical landmarks, mode of ven-
tilation, heart size, respiratory cycle phase and angle of the X-ray 
can affect measurement of distance between the UAC tip and the 
aortic valve. The monitor filter settings used were standard on our 
NICU; increasing the BP low pass filter cut-off frequency could 
achieve a less smoothed waveform and help improve resolution 
for BP waveform peak and trough as well as better visual feature 
identification such as the dicrotic notch. We have specified the 
filter settings used as the monitor signal processing as well as BP 
measurement site could affect this analysis.
Conclusions
This pilot study has highlighted the importance of HR 
when assessing physiological variables related to PDA. We 
observed significant relationships between PDA diameter 
and BP waveform characteristics normalised for in extremely 
preterm infants. The phase difference between ECG and 
BP waveforms as well as BP waveform characteristics are 
straightforward to implement using routinely monitored 
waveforms and so potentially could be incorporated in moni-
tors to allow continuous PDA function assessment.
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